BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update

MELVILLE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results for the third quarter ended September 30, 2025 and provided an update on its business. “As energized as we are by the strong clinical development advancement and positive business momentum that has characterized 2025 so far, in many ways, we are even mor ...